DALLAS, June 4, 2018 /PRNewswire/ — Eclipse has announced the formation of its Medical and Scientific Advisory Board (M&SAB) for 2018. This prestigious group is made up of four highly respected physicians and key opinion leaders in addition to our new President of Regenerative Medicine. Together this board will provide expertise in both clinical and scientific research…
Prior to founding Eclipse in 1993, Tom held several leadership positions throughout his career in the medical device industry. Having mastered both disposable and capital equipment sales for companies like C.R. Bard, Tom’s track record of success quickly established Eclipse as the go-to company to launch new technology in the surgical laser industry.
Over time Tom transitioned Eclipse from a leader in the OR surgical laser market to a key player in the aesthetic laser industry. Starting in 2011 Eclipse began a new mission of increasing adoption of Platelet-rich Plasma on a national level.
His vision and leadership has helped Eclipse become one of the most successful medical device companies in its space. Tom’s new mission is to bring game-changing Eclipse technologies in Platelet-Rich Plasma, Microneedling and Shockwave Therapy to the entire globe.